Mycophenolate mofetil with or without tracolimus (FK506) as a second line treatment for steroid-resistant acute graft-versus-host disease.: The experience of Saint Louis Hospital

被引：0
|
作者：
Fisher, G. [1 ]
Rocha, V. [1 ]
Dos Santos, M. [1 ]
Devergie, A. [1 ]
Robin, M. [1 ]
de Latour, R. Peffault [1 ]
Ribaud, P. [1 ]
Ferry, C. [1 ]
Gluckman, E. [1 ]
Socie, G. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [1] Myeophenolate mofetil (MMF) with or without tracolimus (FK506) as a second line treatment for steroid-resistant acute graft-versus-host disease. the experience of Saint Louis Hospital.
    Fisher, Gustavo
    Rocha, Vanderson
    dos Santos, Moema
    Devergie, Agnes
    Robin, Marie
    de Latour, Regis P.
    Ribaud, Patricia
    Ferry, Christele
    Gluckman, Eliane
    Socie, Gerard
    BLOOD, 2006, 108 (11) : 819A - 819A
  • [2] FK506 (TACROLIMUS) IN THE TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
    KOEHLER, MT
    HOWRIE, D
    MIRRO, J
    NEUDORF, S
    BLATT, J
    COREY, S
    WOLLMAN, M
    KELLYEKEROTH, V
    REYES, J
    BONE MARROW TRANSPLANTATION, 1995, 15 (06) : 895 - 899
  • [3] Treatment of steroid-resistant acute graft-versus-host disease
    不详
    HAEMATOLOGICA, 2004, 89 (11) : 1408 - 1408
  • [4] Salvage therapy with mycophenolate mofetil and FK-506 for refractory chronic graft-versus-host disease.
    Mookerjee, B
    Altomonte, V
    Vogelsang, G
    BLOOD, 1998, 92 (10) : 457A - 457A
  • [5] Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506)
    Ahmad, SM
    Stegman, Z
    Fructhman, S
    Asbell, PA
    CORNEA, 2002, 21 (04) : 432 - 433
  • [6] Treatment of acute graft-versus-host disease with FK 506
    Wolff, D
    Becker, C
    Kurschner, D
    Skibbe, T
    Ponisch, W
    Kubel, M
    Helbig, W
    BONE MARROW TRANSPLANTATION, 1998, 21 : S123 - S123
  • [7] Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
    D Wolff
    V Roessler
    B Steiner
    S Wilhelm
    V Weirich
    J Brenmoehl
    M Leithaeuser
    N Hofmeister
    C Junghanss
    J Casper
    G Hartung
    E Holler
    M Freund
    Bone Marrow Transplantation, 2005, 35 : 1003 - 1010
  • [8] Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease
    Shaughnessy, PJ
    Bachier, C
    Grimley, M
    Freytes, CO
    Callander, NS
    Essell, YH
    Flomenberg, N
    Selby, G
    Lemaistre, CE
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (03) : 188 - 193
  • [9] Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
    Wolff, D
    Roessler, V
    Steiner, B
    Wilhelm, S
    Weirich, V
    Brenmoehl, J
    Leithaeuser, M
    Hofmeister, N
    Junghanss, C
    Casper, J
    Hartung, G
    Holler, E
    Freund, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 1003 - 1010
  • [10] Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease
    Tse, JC
    Moore, TB
    PHARMACOTHERAPY, 1998, 18 (05): : 988 - 1000
12345